The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis
Open accessAbstract
Neutrophil-to-lymphocyte ratio and lymphocyte
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia
Li, K., Wu, J., Wu, F., Guo, D., Chen, L., Fang, Z., & Li, C. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000672 · Cited by 1,268
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25770 · Cited by 1,047
Wang, K., Zuo, P., Liu, Y., Zhang, M., Zhao, X., Xie, S., Zhang, H., Chen, X., & Liu, C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa538 · Cited by 288
Okugawa, Y., Toiyama, Y., Yamamoto, A., Shigemori, T., Ide, S., Kitajima, T., Fujikawa, H., Yasuda, H., Hiro, J., Yoshiyama, S., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003239 · Cited by 280
Kaasch, A. J., Fowler, V. G., Rieg, S., Peyerl‐Hoffmann, G., Birkholz, H., Hellmich, M., Kern, W. V., & Seifert, H. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir320 · Cited by 136
Cited by
Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., et al. (2020) · Science · doi:10.1126/science.abc8511 · Cited by 1,509
Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C., Zhang, M., Tan, J., Xu, Y., Song, R., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02374-0 · Cited by 1,082
Troyer, E. A., Kohn, J. N., & Hong, S. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.027 · Cited by 964
Biomarkers associated with COVID-19 disease progression
Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1770685 · Cited by 890
COVID-19 and the human innate immune system
Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714
“…lymphopenia has been identified as a hallmark of severe COVID-19 (Guan et al., 2020; Huang et al., 2020), and an elevated neutrophil/lymphocyte ratio has been introduced as a biomarker of disease severity (Kuri-Cervantes et al., 2020; Lagunas-Rangel, 2020; Liu et al., 2020; Qin et al., 2020).”
BackgroundThe hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Abou-Ismail, M. Y., Diamond, A., Kapoor, S., Arafah, Y., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.029 · Cited by 694
Immune determinants of COVID-19 disease presentation and severity
Brodin, P. (2021) · Nature Medicine · doi:10.1038/s41591-020-01202-8 · Cited by 663
The many faces of the anti-COVID immune response
Vardhana, S. A., & Wolchok, J. D. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200678 · Cited by 509
Drugging the efferocytosis process: concepts and opportunities
Mehrotra, P., & Ravichandran, K. S. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00470-y · Cited by 459
Vascular occlusion by neutrophil extracellular traps in COVID-19
Leppkes, M., Knopf, J., Naschberger, E., Lindemann, A., Singh, J., Herrmann, I., Stürzl, M., Staats, L., Mahajan, A., Schauer, C., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102925 · Cited by 446
Berenguer, J., Ryan, P., Rodríguez-Baño, J., Jarrín, I., Carratalà, J., Pachón, J., Yllescas, M., Arriba, J. R., Aznar Muñoz, E., Gil Divasson, P., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.024 · Cited by 401
Li, X., Liu, C., Mao, Z., Xiao, M., Wang, L., Qi, S., & Zhou, F. (2020) · Critical Care · doi:10.1186/s13054-020-03374-8 · Cited by 380
Low testosterone levels predict clinical adverse outcomes in SARS‐CoV‐2 pneumonia patients
Rastrelli, G., Di Stasi, V., Inglese, F., Beccaria, M., Garuti, M., Di Costanzo, D., Spreafico, F., Greco, G. F., Cervi, G., Pecoriello, A., et al. (2021) · Andrology · doi:10.1111/andr.12821 · Cited by 360
Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19
Ali, N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26097 · Cited by 357
Ghahramani, S., Tabrizi, R., Lankarani, K. B., Kashani, S. M. A., Rezaei, S., Zeidi, N., Akbari, M., Heydari, S. T., Akbari, H., Nowrouzi-Sohrabi, P., et al. (2020) · European Journal of Medical Research · doi:10.1186/s40001-020-00432-3 · Cited by 355
Biomarkers in COVID-19: An Up-To-Date Review
Samprathi, M., & Jayashree, M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.607647 · Cited by 290
Frederiksen, L. S. F., Zhang, Y., Foged, C., & Thakur, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01817 · Cited by 287
Najjar, S., Najjar, A., Chong, D. J., Pramanik, B. K., Kirsch, C., Kuzniecky, R. I., Pacia, S. V., & Azhar, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01896-0 · Cited by 282
The value of clinical parameters in predicting the severity of COVID‐19
Shang, W., Dong, J., Ren, Y., Tian, M., Li, W., Hu, J., & Li, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26031 · Cited by 270
Hoertel, N., Sánchez-Rico, M., Vernet, R., Beeker, N., Jannot, A.-S., Neuraz, A., Salamanca, E., Paris, N., Daniel, C., Gramfort, A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01021-4 · Cited by 269
Vanderbeke, L., Van Mol, P., Van Herck, Y., De Smet, F., Humblet-Baron, S., Martinod, K., Antoranz, A., Arijs, I., Boeckx, B., Bosisio, F. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24360-w · Cited by 247
Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
Tomar, B., Anders, H.-J., Desai, J., & Mulay, S. R. (2020) · Cells · doi:10.3390/cells9061383 · Cited by 263
Borges, L., Pithon-Curi, T. C., Curi, R., & Hatanaka, E. (2020) · Mediators of Inflammation · doi:10.1155/2020/8829674 · Cited by 235
Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis
Karimi, A., Shobeiri, P., Kulasinghe, A., & Rezaei, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741061 · Cited by 171
The looming storm: Blood and cytokines in COVID-19
Kaur, S., Bansal, R., Kollimuttathuillam, S., Gowda, A. M., Singh, B., Mehta, D., & Maroules, M. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100743 · Cited by 113
Salman, E., Çelikbilek, N., Aydoğan, S., Özdem, B., Gökay, S., Kırca, F., Toyran, A., Bilici Salman, R., & Dinç, B. (2021) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20219706 · Cited by 15
Metadata
- Authors
- Lagunas‐Rangel, F. A.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2020-04-08
- Volume
- 92
- Issue
- 10
- Pages
- 1733-1734
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W3015130991
- Cited by
- 606
- References
- 11
- FWCI
- 15.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.